A Stage-Appropriate Framework for Startups: Interview with Cherish CEO Sumit Nagpal

Medsider: Learn from MedTech and HealthTech Experts

In this episode of Medsider Radio, we had an interesting chat with Sumit Nagpal, founder and CEO of Cherish Health, a company developing radar-based health and safety monitoring devices.

Over the past three decades, serial entrepreneur and digital health veteran Sumit has co-founded and grown five companies that have tackled some of the boldest challenges faced by the healthcare economy. He also serves on the board of HIMSS and chairs the Nominating Committee.

In this interview, Sumit shares his take on the importance of being stage-appropriate—both mentally and business-wise—and how to recognize patterns in the market by simply listening. Oh - and constantly learn from others because, as Steve Jobs paraphrasing Picasso put it, “great artists steal.”

Before we dive into the discussion, I wanted to mention a few things:

First, if you’re into learning from medical device and health technology founders and CEOs, and want to know when new interviews are live, head over to Medsider.com and sign up for our free newsletter.

Second, if you want to peek behind the curtain of the world's most successful startups, you should consider a Medsider premium membership. You’ll learn the strategies and tactics that founders and CEOs use to build and grow companies like Silk Road Medical, AliveCor, Shockwave Medical, and hundreds more!

We recently introduced some fantastic additions exclusively for Medsider premium members, including playbooks, which are curated collections of our top Medsider interviews on key topics like capital fundraising and risk mitigation, and a curated investor database to help you discover your next medical device or health technology investor!

In addition to the entire back catalog of Medsider interviews over the past decade, premium members also get a copy of every volume of Medsider Mentors at no additional cost, including the latest Medsider Mentors Volume VI. If you’re interested, go to medsider.com/subscribe to learn more.

Lastly, if you'd rather read than listen, here's a link to the full interview with Sumit Nagpal.